BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33948348)

  • 1. B-cell acute lymphoblastic leukemia-related microRNAs: uncovering their diverse and special roles.
    Lv M; Zhu S; Peng H; Cheng Z; Zhang G; Wang Z
    Am J Cancer Res; 2021; 11(4):1104-1120. PubMed ID: 33948348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia.
    Mirzaei H; Fathullahzadeh S; Khanmohammadi R; Darijani M; Momeni F; Masoudifar A; Goodarzi M; Mardanshah O; Stenvang J; Jaafari MR; Mirzaei HR
    J Cell Physiol; 2018 Feb; 233(2):888-900. PubMed ID: 28084621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging roles of microRNAs in acute lymphoblastic leukemia and their clinical prospects.
    Deng W; Pan M; Zhu S; Chao R; Wang L
    Expert Rev Hematol; 2021 Nov; 14(11):987-992. PubMed ID: 34784832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA expression profiles discriminate childhood T- from B-acute lymphoblastic leukemia.
    Almeida RS; Costa E Silva M; Coutinho LL; Garcia Gomes R; Pedrosa F; Massaro JD; Donadi EA; Lucena-Silva N
    Hematol Oncol; 2019 Feb; 37(1):103-112. PubMed ID: 30393877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell acute lymphoblastic leukemia from miRNA perspective: Basic concepts, experimental approaches, and potential biomarkers.
    Drobna M; Szarzyńska-Zawadzka B; Dawidowska M
    Blood Rev; 2018 Nov; 32(6):457-472. PubMed ID: 29703513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA as a prognostic biomarker for survival in childhood acute lymphoblastic leukemia: a systematic review.
    Rashed WM; Hamza MM; Matboli M; Salem SI
    Cancer Metastasis Rev; 2019 Dec; 38(4):771-782. PubMed ID: 31807971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL.
    Ghodousi ES; Aberuyi N; Rahgozar S
    Jpn J Clin Oncol; 2020 Jun; 50(6):671-678. PubMed ID: 32129446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles and clinical implications of microRNAs in acute lymphoblastic leukemia.
    Ultimo S; Martelli AM; Zauli G; Vitale M; Calin GA; Neri LM
    J Cell Physiol; 2018 Aug; 233(8):5642-5654. PubMed ID: 29154447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic miRNA classifiers in t cell acute lymphoblastic leukemia: Study protocol for a systematic review and meta-analysis of observational clinical studies.
    Sabarimurugan S; Madurantakam Royam M; Kumarasamy C; Kodiveri Muthukaliannan G; Samiappan S; Jayaraj R
    Medicine (Baltimore); 2019 Mar; 98(9):e14569. PubMed ID: 30817574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs and acute myeloid leukemia: therapeutic implications and emerging concepts.
    Wallace JA; O'Connell RM
    Blood; 2017 Sep; 130(11):1290-1301. PubMed ID: 28751524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the miRNA expression by TEL/AML1, BCR/ABL, MLL/AF4 and TCF3/PBX1 oncoproteins in acute lymphoblastic leukemia (Review).
    Organista-Nava J; Gómez-Gómez Y; Illades-Aguiar B; Leyva-Vázquez MA
    Oncol Rep; 2016 Sep; 36(3):1226-32. PubMed ID: 27431573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Endogenous Control miRNAs for RT-qPCR in T-Cell Acute Lymphoblastic Leukemia.
    Drobna M; Szarzyńska-Zawadzka B; Daca-Roszak P; Kosmalska M; Jaksik R; Witt M; Dawidowska M
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30241379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities.
    Salehi M; Sharifi M
    J Cell Physiol; 2018 Sep; 233(9):6370-6380. PubMed ID: 29323722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA-155 and miRNA-181a as prognostic biomarkers for pediatric acute lymphoblastic leukemia.
    El-Khazragy N; Noshi MA; Abdel-Malak C; Zahran RF; Swellam M
    J Cell Biochem; 2019 Apr; 120(4):6315-6321. PubMed ID: 30362157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis.
    Momen-Heravi F; Saha B; Kodys K; Catalano D; Satishchandran A; Szabo G
    J Transl Med; 2015 Aug; 13():261. PubMed ID: 26264599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A semantics-oriented computational approach to investigate microRNA regulation on glucocorticoid resistance in pediatric acute lymphoblastic leukemia.
    Chen H; Zhang D; Zhang G; Li X; Liang Y; Kasukurthi MV; Li S; Borchert GM; Huang J
    BMC Med Inform Decis Mak; 2018 Jul; 18(Suppl 2):57. PubMed ID: 30066657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulated microRNA expression profiles in cholangiocarcinoma cell-derived exosomes.
    Kitdumrongthum S; Metheetrairut C; Charoensawan V; Ounjai P; Janpipatkul K; Panvongsa W; Weerachayaphorn J; Piyachaturawat P; Chairoungdua A
    Life Sci; 2018 Oct; 210():65-75. PubMed ID: 30165035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six Candidate miRNAs Associated With Early Relapse in Pediatric B-Cell Acute Lymphoblastic Leukemia.
    Amankwah EK; Devidas M; Teachey DT; Rabin KR; Brown PA
    Anticancer Res; 2020 Jun; 40(6):3147-3153. PubMed ID: 32487609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA: Relevance to stroke diagnosis, prognosis, and therapy.
    Mirzaei H; Momeni F; Saadatpour L; Sahebkar A; Goodarzi M; Masoudifar A; Kouhpayeh S; Salehi H; Mirzaei HR; Jaafari MR
    J Cell Physiol; 2018 Feb; 233(2):856-865. PubMed ID: 28067403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes and microRNAs: New potential therapeutic candidates in Alzheimer disease therapy.
    Iranifar E; Seresht BM; Momeni F; Fadaei E; Mehr MH; Ebrahimi Z; Rahmati M; Kharazinejad E; Mirzaei H
    J Cell Physiol; 2019 Mar; 234(3):2296-2305. PubMed ID: 30191975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.